Pieter C. Limburg

4.9k total citations
79 papers, 3.8k citations indexed

About

Pieter C. Limburg is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Pieter C. Limburg has authored 79 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 27 papers in Pulmonary and Respiratory Medicine and 25 papers in Rheumatology. Recurrent topics in Pieter C. Limburg's work include Vasculitis and related conditions (25 papers), T-cell and B-cell Immunology (15 papers) and Systemic Lupus Erythematosus Research (13 papers). Pieter C. Limburg is often cited by papers focused on Vasculitis and related conditions (25 papers), T-cell and B-cell Immunology (15 papers) and Systemic Lupus Erythematosus Research (13 papers). Pieter C. Limburg collaborates with scholars based in Netherlands, Pakistan and Germany. Pieter C. Limburg's co-authors include Cees G. M. Kallenberg, Coen A. Stegeman, Marc Bijl, Wayel H. Abdulahad, Johanna Westra, Gerda Horst, Berber Doornbos‐van der Meer, Minke G. Huitema, Sebastian Dolff and Johan Bijzet and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer.

In The Last Decade

Pieter C. Limburg

79 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pieter C. Limburg Netherlands 38 1.7k 1.2k 1.1k 670 459 79 3.8k
P. C. Limburg Netherlands 33 1.3k 0.7× 1.3k 1.0× 1.0k 0.9× 543 0.8× 282 0.6× 52 3.6k
W. Joseph McCune United States 43 3.1k 1.8× 3.6k 2.9× 708 0.6× 944 1.4× 412 0.9× 99 6.2k
J. W. Cohen Tervaert Netherlands 36 1.3k 0.8× 1.1k 0.9× 2.6k 2.3× 528 0.8× 322 0.7× 77 3.8k
Lazaros I. Sakkas Greece 38 1.6k 1.0× 1.6k 1.3× 549 0.5× 716 1.1× 676 1.5× 151 4.6k
Riccardo Melicòni Italy 33 593 0.3× 1.6k 1.3× 973 0.9× 448 0.7× 521 1.1× 137 3.5k
Philippe Guilpain France 34 814 0.5× 885 0.7× 1.4k 1.2× 748 1.1× 349 0.8× 126 3.4k
Boris Gilburd Israel 39 2.2k 1.3× 2.2k 1.8× 323 0.3× 857 1.3× 712 1.6× 146 4.5k
María Orietta Borghi Italy 43 1.8k 1.1× 3.3k 2.7× 431 0.4× 679 1.0× 444 1.0× 174 5.5k
Shinsuke Yasuda Japan 32 993 0.6× 1.8k 1.5× 316 0.3× 474 0.7× 346 0.8× 163 3.2k
Mami Tamai Japan 30 1.0k 0.6× 1.7k 1.4× 438 0.4× 689 1.0× 399 0.9× 219 3.4k

Countries citing papers authored by Pieter C. Limburg

Since Specialization
Citations

This map shows the geographic impact of Pieter C. Limburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter C. Limburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter C. Limburg more than expected).

Fields of papers citing papers by Pieter C. Limburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter C. Limburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter C. Limburg. The network helps show where Pieter C. Limburg may publish in the future.

Co-authorship network of co-authors of Pieter C. Limburg

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter C. Limburg. A scholar is included among the top collaborators of Pieter C. Limburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter C. Limburg. Pieter C. Limburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westra, Johanna, et al.. (2011). HMGB1 Is An Important Mediator in Cutaneous Inflammation in Systemic Lupus Erythematosus (SLE). Data Archiving and Networked Services (DANS). 1 indexed citations
2.
Westra, Johanna, et al.. (2011). High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Research & Therapy. 13(3). R71–R71. 135 indexed citations
3.
Arends, Suzanne, E. van der Veer, Henk Groen, et al.. (2011). Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis. The Journal of Rheumatology. 38(8). 1644–1650. 38 indexed citations
4.
Bijzet, Johan, et al.. (2010). Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(8). 1390–1395. 27 indexed citations
5.
Westra, Johanna, Elisabeth Brouwer, Berber Doornbos‐van der Meer, et al.. (2009). Role for CaMKII Inhibition in Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 1173(1). 706–711. 14 indexed citations
6.
Abdulahad, Wayel H., Cornelis Kallenberg, Pieter C. Limburg, & Coen A. Stegeman. (2008). Urinary CD4 effector memory T cells as a measure of renal disease activity in ANCA-associated vasculitis. Data Archiving and Networked Services (DANS). 117(9). 129–129. 1 indexed citations
7.
Reefman, Esther, et al.. (2007). Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcγ receptor–dependent mechanism. Arthritis & Rheumatism. 56(10). 3399–3411. 41 indexed citations
8.
Rossum, André P. van, Hendri H. Pas, Fausto Fazzini, et al.. (2006). Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small‐vessel vasculitis. Arthritis & Rheumatism. 54(3). 986–991. 53 indexed citations
9.
Westra, Johanna, Sigrídur A. Ásgeirsdóttir, Robbert J. Kok, et al.. (2005). Differential effects of NF-κB and p38 MAPK inhibitors and combinations thereof on TNF-α- and IL-1β-induced proinflammatory status of endothelial cells in vitro. American Journal of Physiology-Cell Physiology. 289(5). C1229–C1239. 127 indexed citations
10.
Rossum, André P. van, Pieter C. Limburg, & Cees G. M. Kallenberg. (2005). Activation, Apoptosis, and Clearance of Neutrophils in Wegener's Granulomatosis. Annals of the New York Academy of Sciences. 1051(1). 1–11. 27 indexed citations
11.
Reefman, Esther, Pieter C. Limburg, Cees G. M. Kallenberg, & Marc Bijl. (2005). Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy. Annals of the New York Academy of Sciences. 1051(1). 52–63. 27 indexed citations
12.
Stegeman, Coen A., et al.. (2002). Neutrophil Membrane Expression of Proteinase 3 (PR3) Is Related to Relapse in PR3-ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 13(9). 2232–2238. 139 indexed citations
13.
Boomsma, Maarten M., Coen A. Stegeman, Cees G. M. Kallenberg, et al.. (2001). Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. Journal of Immunological Methods. 254(1-2). 47–58. 22 indexed citations
14.
Nijsten, Maarten W., Peter Olinga, Hauw The, et al.. (2000). Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Critical Care Medicine. 28(2). 458–461. 234 indexed citations
15.
Roozendaal, Caroline, et al.. (2000). Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. Journal of Hepatology. 32(5). 734–741. 78 indexed citations
16.
Verschuuren, Erik A.M., Martin C. Harmsen, Pieter C. Limburg, et al.. (1999). Towards Standardization of the Human Cytomegalovirus Antigenemia Assay. Intervirology. 42(5-6). 382–389. 5 indexed citations
17.
Schirm, Jurjen, Willem J. van Son, Wim van der Bij, et al.. (1999). Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients. Journal of Clinical Virology. 14(3). 153–165. 9 indexed citations
18.
19.
Mulder, A. H. L., Gerda Horst, Elizabeth B. Haagsma, et al.. (1993). Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology. 17(3). 411–417. 164 indexed citations
20.
Tervaert, Jan Willem Cohen, Pieter C. Limburg, Job D. Elema, et al.. (1991). Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. The American Journal of Medicine. 91(1). 59–66. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. C. Limburg Breakdown of academic impact, for papers by W. Joseph McCune Breakdown of academic impact, for papers by J. W. Cohen Tervaert Breakdown of academic impact, for papers by Lazaros I. Sakkas Breakdown of academic impact, for papers by Riccardo Melicòni Breakdown of academic impact, for papers by Philippe Guilpain Breakdown of academic impact, for papers by Boris Gilburd Breakdown of academic impact, for papers by María Orietta Borghi Breakdown of academic impact, for papers by Shinsuke Yasuda Breakdown of academic impact, for papers by Mami Tamai
Rankless by CCL
2026